Table of contents
At a glance
What do you need to validate in Benchling Validated Cloud?
Validate the actual data and decision path across the tenant, release, schema, review workflow and connected applications. Assess sample linkage, data entry, submission, substantive review and retained records separately. Supplier evidence can cover relevant product features, while your configuration and use still need assessment. A submitted value, completed entry review and readable export demonstrate different parts of the process.
- Validated Cloud is a segregated offering; general Benchling functions are not automatically available in every tenant.
- Data entry, submit, and technical review represent different states.
- Display precision, stored value, and business decision logic must be consistent.
- Manufacturer records and batch release information need to be linked to the actual customer configuration.
1. Define validated cloud environment and specify the concrete use of results
Benchling offers Validated Cloud as a controlled cloud deployment with its own tenant and regulated release cycles. Document the actual applications and activated features in use within this environment. An academic account, a general research tenant, or a product demo does not constitute evidence of the same configuration. Similarly, a workflow that appears similar may still entail different permissions or change controls.
Start with a specific intended use: for example, a validated result from a defined laboratory procedure that supports a defined quality decision. Describe data origin, sample, method, calculation, and recipient. This article addresses human medicinal product GMP; exploratory research, clinical trials, or other regulatory areas require their own assessment. Research is not automatically excluded from relevant system controls merely due to its designation.
Public documents describe the release 2026.3 with production upgrade in September 2026. For your inventory, however, the actual active customer status including patches and functions counts. The term "Validated" does not replace the evaluation of the intended use or the decision which delivery documents are transferable to it.
2. Consider the notebook, results, and registry as an interconnected pathway
Capture result tables to document structured results within a notebook entry. After help is accessed, unsubmitted rows do not appear at the corresponding registry entity. Only upon Submit do the data get linked to this context. Therefore, document where a user enters a value and which view a subsequent user considers as the basis.
The association to the entity is just as important as the numerical value. A correctly calculated value for the wrong sample remains professionally incorrect. Verify selection, identifier, and relevant relationships using deliberately similar samples. When data is transferred from a worklist or table, it must be clearly traceable which source dataset led to the final result.
A status should convey a clear and unambiguous statement. "Present" does not automatically imply completeness, and "submitted" does not automatically imply technical evaluation. Define which results may be used in a report or further calculation. This operational rule must be specifically reviewed; it must not be inferred solely from the visibility of a value.
3. Assign schema and provide evidence for each data state
The Result schema specifies mandatory fields and data types. The help text describes corresponding validations during Submit. These checks can identify empty mandatory values or incorrect data types; however, a numerically valid value may still correspond to the wrong sample, unit, or method. Therefore, separate technical input validation and subject-matter acceptance should be included in your requirements.
The following matrix is an internal work aid. For each row, specify the exact schema and configuration status as well as the identified delivery note. Where the source only describes a general function, evidence of customer-specific implementation remains required. Explicitly include a missing value and a formally correct but incorrectly assigned data record.
| Object or condition | Documented Function | Still open statement | Targeted evidence |
|---|---|---|---|
| Entry with result row | Structured data capture | Correct sample, method, and unit? | Compare source and entity references |
| Mandatory field verification | Schema controls completeness/type | Is the content technically accurate? | Blank value and incorrect sample assignment |
| Submit | Result appears in Registry context | Has a suitably qualified person already reviewed it? | Compare entry-/result-/review status |
| Entry-Review | Configured inspection step | Has the authorized role assessed the correct status? | Check, significance, and re-opening of roll |
| Export | Release of data and context | Are required relationships and documents included? | Compare original context and output |
| Release record | Manufacturer describes system change | Does this apply to our schema or our app? | Assign configurations and changes purposefully. |
4. Submit and professional review to be conducted separately and under controlled review
Benchling describes self-review as well as parallel and sequential review processes. Roles, stages, significance, and completion status are configurable. Select an execution that aligns with the requirements of your process. The provided self-review function is neither a general regulatory authorization nor automatically constitutes a deviation. What is critical is the necessary authorization and, where applicable, the required independence.
For review, structured tables that have not been submitted may not remain in the system. After submission for review, the entry for changes is locked; reopening restores it to "In Progress" and enables editing. Therefore, in addition to verifying successful closure, review corrections, reopenings, and the subsequent need for a renewed decision.
Describe what an auditor actually evaluates: sample assignment, completeness, method, calculation, and relevant changes. The presence of a configured button name such as "Approve" does not constitute evidence of this content. The question of signature is assessed based on the applicable regulatory framework and specific workflow; the applicability of FDA Part 11 does not automatically follow from the use of an electronic review.
5. Example: Same display, different decision
This scenario does not constitute a performed Benchling test nor a validated laboratory method. Three samples, P17, P18, and P19, are expected. The example instruction evaluates the unrounded value against the range of 8.000 to 12.000 mg/mL, inclusive of the limits. A display with two decimal places serves only for presentation purposes. Actual methods may employ other technically justified rounding rules.
P17 receives 8.004 mg/mL, P18 receives 7.996 mg/mL; the required value for P19 is missing. Both available values appear rounded to 8.00. Therefore, the reviewer's assessment pertains to stored values, correct entity, completeness, and review status. A missing measurement is not supplemented by a substitute value or an arbitrary average.
| Test case | Input or state | Independently established expected result | Decision or evidence |
|---|---|---|---|
| P17 | 8.004 mg/mL; Display 8.00 | 8.004 − 8.000 = 0.004 above the lower limit | Within example rules; separate review for professional assessment |
| P18 | 7.996 mg/mL; Display 8.00 | 8.000 − 7.996 = 0.004 below the lower limit | Do not evaluate as appropriate through rounded display. |
| P19 | Required value missing | 3 expected − 2 present = 1 missing | Do not claim a complete results status. |
| Incorrect sample withdrawal | P17 value inadvertently assigned to P18 | Value remains plausible; identity is incorrect | Identify misassignments and reliably correct and report them. |
| Reopening | Approved entry is opened for correction | A new state can be edited. The earlier closed state is not overwritten. | Change and repeated necessary decision safeguarding |
| Export | Report shows only 8.00 for P17/P18 | Release may not conceal different decision criteria. | Supply the required precision and context or select a suitable output |
6. Test precision across input, resubmission and output
Verify the agreed calculation pathway using independently determined target values. This includes unit, decimal format, displayed value, stored value, and re-submission following modification. According to manufacturer guidance, the locale setting affects the display and reading of numerical and date values. A simple visual comparison may therefore be insufficient.
A manufacturer notice from September 2025 describes a historical effect observed upon resubmission of specific result values with schema display precision. The notice explicitly distinguishes this issue from registration tables and announces a correction for Validated Cloud 2025.4. This serves as a basis for a targeted review of our own release process, not evidence that the error currently persists broadly.
Inquire regarding potential impact for older data and regarding the actually expected behavior for current checks. Maintain the necessary precision and change history for your decision-making. This does not lead to a blanket prohibition on rounding: display and evaluation rules must align with the approved method and the purpose of documentation.
7. Verify exports against their subsequent traceability purpose
A readable report can be suitable for the recipient without replacing the complete electronic record. Define which data, documents, relationships, review information, and changes will be required later. Assess the selected output format accordingly. The absence of context cannot be remedied solely by an aesthetically pleasing PDF layout.
Benchling has documented a previously resolved export error for the period 4 to 12 December 2025. Certain entry metadata and review information were missing from exports and review snapshots; the underlying data remain intact according to the vendor. This clear time boundary is significant. The note does not indicate a general incompleteness of current exports.
For potential legacy data, it must be determined whether previously generated records are relevant and whether new records need to be created. For the current approach, representative exports including associated documentation and review context should be assessed. Separate arrangements are required for retention purposes, retention period, and access after contract termination; routine supplier backups do not fully address these requirements.
8. Apps, browsers, and alternative access paths to the system scope are included
API imports or additional apps may alter the approved data pathway. Public developer support assigns GxP tenants to the legacy app framework and documents missing app version history and immediately effective manifest updates within that framework. Confirm this documentation boundary for your actual tenant. Functions of a newer app framework must not be assumed without proper evaluation.
For a connected data path you need comprehensible assignment, permission and error handling. Check whether a new import adds, changes or double creates a result. The concrete expectation is to be defined in advance; an app connection alone does not guarantee correct sample identity or controlled repetition.
Benchling describes the platform as online dependent and without local server or offline version. Plan, therefore, how an affected work step is interrupted in case of connection failure controlled and continued later. Mobile browsers are not tested in the same way with updates according to help. A required mobile use therefore requires an explicit suitability evaluation.
9. Organize delivery notes and quarterly releases in SMEs
The validated Cloud is described with controlled releases, preview environment, release impact assessment, and validation documentation. Review the actual available package against your requirements and configuration. A manufacturer certificate for a standard feature can be valuable; for local schemas, formulas, rights, and external data sources, its coverage must be clearly demonstrable.
Assign a subject-matter and technical point of contact for each relevant change. The laboratory shall specify the use of results, QA shall define the traceability expectations within the quality system, and IT shall outline the components and handover procedures. Operational decision authority shall be formally established. Forecasting period is only applicable when example values, required outcomes, and responsible reviewers are pre-defined.
Effort drivers include, among other things, different result schemas, formulas, review pathways, data imports, and historical inventories. Start with a narrowly defined process and document the actually used variants. A fixed validation duration cannot be derived from quarterly cycles or manufacturer packaging. Similarly, patches and hotfixes have their own information, the relevance of which must be assessed.
10. Checklist for a reliable result pathway
The following internal reference document consolidates the decision-making framework for the defined process. Each relevant point shall be linked to an identifiable justification. A new schema or review version should later be evaluated against this boundary definition.
The technical assessment does not substitute for a professional method evaluation. Similarly, a correctly conducted review process does not automatically substitute for the evaluation of all associated data. What is essential is whether the specific result remains appropriate and traceable in the context for the intended decision.
- Validated-Cloud-Tenant, Release, Applications and active functions are recorded.
- Sample identity, data origin, method, and units are clearly assigned.
- Critical values, incorrect assignments, and repeated submits have specific expected outcomes.
- Display, stored precision, and decision logic are consistent.
- Entry-, result-, registry-, and review status are correctly interpreted.
- Roles, re-opening and relevant changes have been reviewed.
- Required export context, documentation, and subsequent storage have been determined.
- Delivery notes, release assessment, failure procedures, and usage decisions are the responsibility of the responsible parties.
Project experience and collaboration
Trace a laboratory value through to the decision that relies on it
A laboratory value needs a sample, a method and an evaluation rule to be interpreted. With the laboratory and IT, we trace a value from entry through submission for review to final output. We also check whether identical-looking displays can mask different decisions. One schema may need focused tests of mapping and precision. For several apps, review workflows or historical datasets, we first identify the data relationships. Your actual Benchling environment and its supplier documentation determine what additional evidence is needed.
Frequent Questions About Benchling Results and Evidence
Is each Benchling account suitable for the same GxP application?
No. Validated Cloud is a separately defined offering featuring controlled releases and supporting evidence. Capture actual tenant, applications, and configurations. A function from the general help may require additional activations. Whether your specific process is adequately represented and supported must be assessed based on intended use and risk; account or product naming alone is insufficient.
Why is a value in the entry not yet visible at the sample level?
After consulting the Result-Help, lines that have not been submitted do not appear in the Registry until a Submit action is performed. Therefore, verify the status of the specific line and potential schema errors. Separately, the question remains whether the value has been professionally reviewed for technical accuracy. A downstream user must not, from a Registry visibility standpoint, infer more than the actual data and review rules you have established.
Does a result schema automatically identify the wrong sample?
The described check verifies configured mandatory fields and data types. A formally valid sample reference may still be incorrectly selected from a technical standpoint. Explicitly test such a misassignment and evaluate the transition from work list or import. An appropriate additional control depends on your specific application; therefore, general automated misassignment detection is not substantiated.
Can authors verify their own entries?
Benchling offers a self-review process and configurable automated participation in other review pathways. Whether this aligns with your specific GMP process must be assessed separately based on necessary authorizations, responsibilities, and potential independence. The technical feasibility does not constitute general regulatory approval. Conversely, Annex 11 does not permit a one-size-fits-all identical role segregation for every entry.
What occurs professionally after re-opening a validated entry?
The assistance describes that reopening enables processing and resets the status to In Progress. Define which changes are permitted and which subsequent re-evaluation is required. Also review follow-up results and outputs. A previous review must not be used as evidence for a currently altered content without a current assessment.
Are rounding in Benchling fundamentally unacceptable?
No. Your method must specify the level of precision used for calculation, evaluation, and reporting. In the example provided in this article, unrounded values are compared; therefore, values such as 8.004 and 7.996, despite identical displayed results, must not be considered equal. The historical vendor note regarding re-submission must be interpreted on a version-specific basis. It does not establish a general prohibition on rounding nor indicate a current error occurring in every tenant.
Can a PDF export replace the electronic results record?
A PDF may only be considered as a substitute if it fully and appropriately contains the information required for the intended audit purpose. Review values, sample traceability, attachments, review details, and other relevant contextual elements. Legibility alone is insufficient. The documented, resolved export error from December 2025 serves as a basis for targeted examination of potential historical exports. This does not lead to a general conclusion regarding current export activities.
Does the validation lead take responsibility for our entire process qualification?
The binder must be verified for its actual coverage; a complete transfer of your process validation cannot be generally inferred from this. The product specification references supporting evidence and IQ/OQ documentation; the communication plan identifies additional release documentation. Assign these to your specific requirements and versions. Customer-specific schemas, calculations, roles, data sources, and result usage must be supported by appropriate documentation or deliberately supplemented.
Can we continue using Benchling offline during an internet outage?
The manufacturer support document does not include an offline version or a local server installation. Therefore, a controlled interruption and restart procedure must be planned for affected activities. If alternative records are used temporarily, clear rules for transfer, assignment, and potential duplication must be established. Such a procedure must be appropriate for your process; it does not automatically occur through autosave or a vendor backup.
Which preparation reduces your own voting effort?
Prepare a concise list of efficient schemata, review processes, formulas, and data transfer protocols, together with representative example values. Assign a technical responsible party and existing supplier documentation to each point. This enables targeted evaluation of changes in the preview. This practical preparation supports planning but does not provide a general duration or cost forecast for your project.
Sources and review date
As of 6 October 2026. Focus: Benchling Validated Cloud; publicly documented release 2026.3, general help pages with independent update status. Separate verification of tenant, features, and actually active patches. Historical precision and export notes are time-bound; no general current defects are asserted. Validation binder not fully reviewed. Human medicinal product GMP with Annex 11 and Chapters 4/6; examples are internal reference guides, not product runs.
- Benchling Validated Cloud
- Benchling Validated Cloud Communications
- 2026.3 Benchling Validated Cloud Release
- Capture data with Results
- Create and use review processes
- Rounding Behavior in Result and Registration Structured Tables
- Notebook Entry Export Metadata Issue
- Legacy Apps Overview
- Navigate your Benchling account
- European Commission: EudraLex Volume 4
- EU GMP Annex 11: Computerised Systems, January 2011 revision
- EU GMP Chapter 4: Documentation, January 2011
- FDA: Part 11, Electronic Records; Electronic Signatures — Scope and Application
- EU-GMP Chapter 6: Quality Control
Sources checked: .
Ensure traceability of the Benchling result pathway
We support you in defining the specific data pathway, evaluating supplier certifications, and preparing appropriate checks for schema, review, interfaces, and output.
- Cloud and SaaS validation →
Maintain the validated state of cloud and SaaS systems as suppliers issue new versions. We define the boundary between your responsibilities and the supplier’s and agree how each release will be assessed.

